Literature DB >> 7800214

Comparative mortality from cardiovascular disease in patients with chronic renal failure.

J H Brown1, L P Hunt, N P Vites, C D Short, R Gokal, N P Mallick.   

Abstract

Patients with chronic renal failure show an excess mortality from cardiovascular disease (CVD). Over a 4-year period (1983-1986) we have prospectively studied 305 patients (177 men, 128 women) from a geographically constrained population entering a renal replacement therapy (RRT) programme. The development of new cardiovascular events and patient survival have been documented up to the end of 1990. We have determined the incidence of CVD amongst the patients compared to the general population of the region and assessed the predictive value for future cardiovascular events of risk factors present at the start of RRT. One hundred and fourteen patients experienced a new cardiovascular event. One hundred and fifteen patients died, 89 from CVD. Stratification by age and sex identified diabetes, previous coronary heart disease, and cardiomegaly to be significantly associated with an increased risk of a cardiovascular event, and diabetes, previous coronary heart disease, and accelerated hypertension to be significantly associated with an increased risk of cardiovascular death. Mortality from CVD was 10.1 times that of the corresponding general population, and was increased 44 times for patients with diabetes. Duration of RRT did not influence mortality rates. This excessive early mortality has significant implications for RRT programmes and further research is necessary to identify individuals at risk and the modifiable risk factors that could receive targeted interventional therapy.

Entities:  

Mesh:

Year:  1994        PMID: 7800214     DOI: 10.1093/ndt/9.8.1136

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

Review 1.  Endothelial function and the kidney. An emerging target for cardiovascular therapy.

Authors:  T J Rabelink; H A Koomans
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 2.  Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity.

Authors:  Scott E Liebman; Steven P Lamontagne; Li-Shan Huang; Susan Messing; David A Bushinsky
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

3.  Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure.

Authors:  David Saltissi; Justin Westhuyzen; Colleen Morgan; Helen Healy
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

4.  Second manifestations of ARTerial disease (SMART) study: rationale and design.

Authors:  P C Simons; A Algra; M F van de Laak; D E Grobbee; Y van der Graaf
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

5.  Could sarcopenia-related mortality in end-stage renal disease be underpinned by the number of hospitalizations and cardiovascular diseases?

Authors:  Hugo de Luca Corrêa; André Bonadias Gadelha; Baruch Vainshelboim; Maurílio Tiradentes Dutra; João B Ferreira-Júnior; Lysleine Alves Deus; Rodrigo Vanerson Passos Neves; Andrea Lucena Reis; Thaís Branquinho de Araújo; Carmen Tzanno-Martins; Fernanda Silveira Tavares; Rosângela Vieira Andrade; Thiago Dos Santos Rosa
Journal:  Int Urol Nephrol       Date:  2022-07-11       Impact factor: 2.266

6.  Left ventricular morphology and diastolic function in uraemia: echocardiographic evidence of a specific cardiomyopathy.

Authors:  L Facchin; G Vescovo; G Levedianos; L Zannini; M Nordio; S Lorenzi; G Caturelli; G B Ambrosio
Journal:  Br Heart J       Date:  1995-08

7.  Autonomic neuropathy and QT interval in hemodialysed patients.

Authors:  Simona Maule; Massimo Veglio; Fabio Mecca; Chiara Calvo; Guido Martina; Martino Marangella; Roberto Quadri; Paolo Cavallo Perin
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

8.  Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients.

Authors:  Abdul Wase; Abdul Basit; Raja Nazir; Ayman Jamal; Shalin Shah; Tauseef Khan; Ishtiaque Mohiuddin; Cynthia White; Mohammad Saklayen; Peter A McCullough
Journal:  J Interv Card Electrophysiol       Date:  2004-12       Impact factor: 1.900

9.  Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial.

Authors:  Piero Ruggenenti; Manuel Alfredo Podestà; Matias Trillini; Annalisa Perna; Tobia Peracchi; Nadia Rubis; Davide Villa; Davide Martinetti; Monica Cortinovis; Patrizia Ondei; Carmela Giuseppina Condemi; Carlo Maria Guastoni; Agnese Meterangelis; Antonio Granata; Emanuele Mambelli; Sonia Pasquali; Simonetta Genovesi; Federico Pieruzzi; Silvio Volmer Bertoli; Goffredo Del Rosso; Maurizio Garozzo; Angelo Rigotti; Claudio Pozzi; Salvatore David; Giuseppe Daidone; Giulio Mingardi; Giovanni Mosconi; Andrea Galfré; Giorgio Romei Longhena; Alfonso Pacitti; Antonello Pani; Jorge Hidalgo Godoy; Hans-Joachim Anders; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

10.  QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory.

Authors:  Mohamed A Alabd; Walid El-Hammady; Ahmed Shawky; Wail Nammas; Mohamed El-Tayeb
Journal:  Nephron Extra       Date:  2011-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.